New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 21, 2014
08:51 EDTECYTEndocyte price target raised to $44 from $24 at Credit Suisse
Credit Suisse raised Enocyte's price target to $44 from $24 following CHMP's recommendation for approval of vintafolide and etarfolatide for platinum resistant ovarian cancer. Shares are Outperform rated.
News For ECYT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ECYT

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use